Results 201 to 210 of about 22,437 (251)

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation. [PDF]

Blood Adv
Aguirre LE, Kim HT, Elmariah H, Frumm SM, Kelkar AH, Ho V, Gooptu M, Koreth J, Shapiro RM, Romee R, Nikiforow S, Antin JH, Soiffer RJ, Shimony S, Luskin MR, Garcia JS, Chen EC, Wadleigh M, Winer ES, Stone RM, DeAngelo DJ, Al Ali N, Sallman D, Kuykendall A, Sweet K, Lancet JE, Padron E, Chan O, Xie Z, Cutler CS, Komrokji RS, Stahl M.   +31 more
europepmc   +1 more source

Value of MRI Outcomes for Preventive and Early‐Stage Trials in Spinocerebellar Ataxias 1 and 3

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the value of MRI outcomes as endpoints for preventive and early‐stage trials of two polyglutamine spinocerebellar ataxias (SCAs). Methods A cohort of 100 participants (23 SCA1, 63 SCA3, median Scale for the Assessment and Rating of Ataxia (SARA) score = 5, 42% preataxic, and 14 gene‐negative controls) was scanned at 3T up ...
Thiago J. R. Rezende, Emilien Petit, Young Woo Park, Sophie Tezenas du Montcel, James M. Joers, Jonathan M. DuBois, H. Moore Arnold, Michal Povazan, Ipek Özdemir, Guita Banan, Romain Valabregue, Philipp Ehses, Jennifer Faber, Chiadi U. Onyike, Peter B. Barker, Jeremy D. Schmahmann, Eva‐Maria Ratai, Sub H. Subramony, Thomas H. Mareci, Khalaf O. Bushara, Henry Paulson, Thomas Klockgether, Alexandra Durr, Tetsuo Ashizawa, Christophe Lenglet, Gülin Öz, READISCA Investigators   +26 more
wiley   +1 more source

Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS. [PDF]

Blood Cancer J
Komrokji RS, Santini V, Zeidan AM, Sekeres MA, Fenaux P, Raza A, Mittelman M, Thépot S, Buckstein R, Germing U, Madanat YF, Díez-Campelo M, Valcárcel D, Jonášová A, Dougherty S, Shah S, Xia Q, Sun L, Navada S, Feller F, Savona MR, Platzbecker U.   +21 more
europepmc   +1 more source

How are psychosocial risks taught to Canadian occupational medicine residents? [PDF]

Occup Med (Lond)
Durand-Moreau Q, Baillargeon M, Durand-Hémery ML, Patry L, Spilchuk V, Adisesh A.   +5 more
europepmc   +1 more source

Shaping Graduate Medical Education: Synthesis of Stakeholder Input on Training Needs for Physicians. [PDF]

J Grad Med Educ
Kirk LM, Malloy K, Pritchard C, Klingensmith ME.   +3 more
europepmc   +1 more source

Seven ways to get a grip on using participant observation in medical education research. [PDF]

Can Med Educ J
Eady K, Moreau KA.
europepmc   +1 more source

Cardiovascular-kidney-metabolic (CKM) syndrome. [PDF]

Aust Prescr
Dwyer KM, Figtree PE, Oetsch K, Gupta A.
europepmc   +1 more source

2025 Poultry science association annual meeting. [PDF]

Poult Sci
europepmc   +1 more source